title: Does molecular monitoring matter in early-stage breast cancer?
abstract: Serial monitoring of circulating tumor DNA predicts recurrence after treatment for localized breast cancer (Garcia-Murillas et al., this issue).
authors: Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02129, USA. Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
authors: Tilak K
authors: TK
authors: Sundaresan
authors: Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02129, USA. Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. dhaber@mgh.harvard.edu.
authors: Daniel A
authors: DA
authors: Haber
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics*; D005260:Female; D006801:Humans; D009154:Mutation
chemical_list: D004273:DNA, Neoplasm